Comparing two finger-prick tests to find type 2 diabetes in rural China
Compares two finger-prick blood tests for finding type 2 diabetes in at-risk adults.
Plain-language title generated from the registry record
Registry title: Point-of-care Capillary HbA1c Testing for Type 2 Diabetes Screening Among At-risk Individuals in Rural Dali, China
Key facts
- Where
- Dali, ChinaSee the site
Where in China
- The First People's Hospital of DaliDali, ChinaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- The University of Hong Kong
- Trial code
- NCT07718867
- Record updated
- 28 July 2026
- Original description
This project aims to compare Point-of-care capillary HbA1c (POC-cHbA1c) testing and fingerstick random blood glucose (RBG) testing in terms of type 2 diabetes detection rate and cost-effectiveness, in order to optimise current screening strategies for rural populations at high risk of diabetes in rural Dali, China, and to improve treatment adherence and self-management among people with diabetes.Read full original descriptionShow less
Effectiveness and Cost-Effectiveness of Point-of-care Capillary HbA1c Testing for Type 2 Diabetes Screening Among At-risk Individuals in Rural Dali, Yunnan, China: A Cluster Randomised Controlled Trial
This project aims to compare Point-of-care capillary HbA1c (POC-cHbA1c) testing and fingerstick random blood glucose (RBG) testing in terms of type 2 diabetes detection rate and cost-effectiveness, in order to optimise current screening strategies for rural populations at high risk of diabetes in rural Dali, China, and to improve treatment adherence and self-management among people with diabetes.
Inclusion: Aged 18 years or above; Permanent residents of Dali City who have lived locally for at least six consecutive months; Registered as rural residents; No known history of diabetes; Meet at least one of the high-risk criteria for T2DM specified in the Chinese Guidelines for the Prevention and Treatment of Diabetes issued by the Chinese Diabetes Society; Able to understand the study information and provide written informed consent.
Exclusion: Active thyroid disease or other active endocrine disorders at recruitment, such as Cushing's syndrome or acromegaly; Known haemoglobinopathy, severe anaemia, recent acute blood loss, or history of blood transfusion or blood donation within the past three months; Known history of T2DM or currently receiving glucose-lowering treatment; HbA1c testing with a clear result within the past three months, or completion of standardised diabetes screening within the past six months; Currently receiving treatment that may substantially affect interpretation of HbA1c, such as erythropoietin therapy or recent high-dose iron therapy; Pregnant or breastfeeding at the time of recruitment.